MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

Home » Clearpath Robotics snags Intuitive Surgical design guru Hanuschik | Personnel Moves

Clearpath Robotics snags Intuitive Surgical design guru Hanuschik | Personnel Moves

By

Clearpath Robotics snags Intuitive Surgical design guru Hanuschik | Personnel MovesSelf-driving vehicle development company Clearpath Robotics said today it picked up Intuitive Surgical‘s (NSDQ:ISRG) director of design & management Mike Hanuschik.

Hanuschik led the design and product management for Intuitive Surgical’s flagship da Vinci surgical robot system, the market leading robotic surgery platform. The da Vinci is used in over 500,000 procedures annually, according to the company.

“Mike has a proven track record of building world-class teams and developing complex robot systems that are well adopted. He is an inspiring leader who knows how to create and execute an ambitious vision.  We couldn’t be more excited to have him join our executive team,” CEO Matt Rendall said in a press release.

Hanuschik started at Intuitive Surgical with no formal design education, according to a Print Magazine interview.

After leaving his job in the Navy, where he spent his time repairing displays and interfaces for fighter jets, Hanuschik found himself at a job fair Intuitive Surgical was attending. According to Hanuschik, he was offered a choice of either working on the da Vinci system, or on batteries.

He started with the Sunnyvale, Calif.-based company as a product support engineer, moving through product management to become design and management director for the da Vinci system.

Clearpath has tagged Hanuschik as its chief product officer, and said he will help establish and grow Clearpath’s Silicon Valley product design office.

“The 1st thing that stands out about Clearpath is the people. When you walk around the company, there’s a palpable sense of excitement about the work they are doing and it shows in the quality of the products they create. They clearly know how to have fun yet maintain high standards of craftsmanship and a heightened sense of urgency,” Hanuschik said.

 

 JenaValve taps Wulff for CFO
JenaValve said yesterday it has snagged ex-Pure Biosciences CFO and COO Peter Wulff for its new CFO, joining ex-Boston Scientific (NYSE:BSX) general manager Victoria Carr-Brendel who took the reins as CEO in June.
Read more

 St. Jude names Zimmer Biomet’s Dvorak to board
St. Jude Medical (NYSE:STJ) said today it has added Zimmer Biomet‘s (NYSE:ZBH) president and CEO David Dvorak to its board of directors, effective August 4.
Read more

 Ex-AxoGen exec Schiaparelli lands CEO job at Intelomed
InteloMed has named Jill Shiaparelli as its new CEO. Shiaparelli left her position as chief medical officer at AxoGen Inc. (NSDQ:AXGN) in June, to join an at-the-time ‘unnamed’ medical tech company as CEO.
Read more

 Nu-Med Plus adds Merrell as CFO
Nu-Med Plus said yesterday it tagged 30-year accounting vet Kenneth Merrell as its new CFO, replacing outgoing Mark Christensen.
Read more

 Iridex CFO Mackaness steps down
Iridex (NSDQ:IRIX) said yesterday its CFO James Mackaness, who has been with the company since 2008, has stepped down to accept a position as CFO of a different, unnamed company.
Read more

In case you missed it

RSS From Medical Design & Outsourcing

  • BD acquires resorbable polymer maker Tepha
    BD (NYSE:BDX) today announced that it has acquired resorbable polymer technology maker Tepha for an undisclosed amount. Franklin Lakes, N.J.-based BD said that Tepha’s resorbable polymer technology will be used to accelerate BD’s growth of its surgical mesh for soft tissue repair, reconstruction and regeneration. Tepha’s GalaFlex portfolio is also included in the acquisition. Get the… […]
  • Blackrock Neurotech and ClearPoint Neuro want to automate brain implant surgeries
    ClearPoint Neuro (NSDQ:CLPT) announced an agreement with Blackrock Neurotech to develop automated technologies for brain implant surgeries. The partnership will seek to develop an automated surgical solution for implanting brain-computer interfaces (BCIs) into patients with neurological disorders — including from paralysis, ALS, blindness and hearing loss. Solana Beach, Calif.–based ClearPoint Neuro said in a news… […]
  • New Mountain Capital to acquire Flexan
    New Mountain Capital’s ILC Dover today announced that it has reached a definitive agreement to acquire Flexan for an undisclosed amount. Lincolnshire, Ill.–based Flexan is a contract design and manufacturing company specializing in high-precision silicone, rubber and thermoplastic components for the medical device industry. The acquisition will allow both companies to serve a broader client… […]
  • How COVID-19 changed medical device clinical trials forever
    The success of remote clinical trial oversight opens the door to hybrid approaches and creates new possibilities for the future of trials. DeviceTalks Because of the pandemic, virtually overnight, all players involved in medical device clinical trials had to pivot to virtual monitoring to keep trials going. What impact did remote trial oversight have on… […]
  • Nuvasive launches ALIF 3D printed porous titanium implant
    Nuvasive this week announced that it has launched its Modulus ALIF 3D printed porous titanium implant for anterior lumbar interbody fusion. San Diego-based Nuvasive designed Modulus for enhanced osseointegration, according to the company. It has a porous surface architecture engineered for fusion and promotes new bone on-growth and in-growth. The design also allows for enhanced… […]
  • Cardinal Health subsidiary faces federal lawsuit over EtO plant in Georgia
    Nearly two dozen people who have lived in the Augusta, Ga. area are suing Cardinal Health subsidiary Kendall Patient Recovery U.S. over ethylene oxide emissions from a medical device sterilization plant in the city. The people suing KPR U.S. in U.S. District Court in Southern Georgia lived and worked within miles of the Augusta facility… […]
  • FDA seeks expanded authority to boost medical device supply chain
    The FDA announced as part of its annual budget proposal that it will include $21.6 million for a new Resilient Supply Chain and Shortages Prevention Program (RSCSPP). Funding from the RSCSPP for the Center for Devices and Radiological Health (CDRH) will provide — the FDA says, for the first time — resources to establish a… […]
  • Using RVI to prevent contamination and maintain purity of pharmaceuticals 
    Here’s how remote visual inspection (RVI) can help pharma companies prevent contamination and maintain product-line purity requirements. Hafees Fraisada, Olympus Bacterial or foreign-particle contamination in production-line equipment can cause serious health issues for consumers and shake public confidence in the industry. Strict purity and contamination control of pharmaceutical manufacturing facilities is required under various international… […]
  • The 18 most innovative medical devices of 2021
    The Galien Foundation today announced the nominees for most innovative medical devices for its 15th annual Prix Galien USA Awards. The foundation nominates devices, biotechnology and pharmaceutical products for its annual Prix Galien awards to highlight products designed to improve the human condition. “The Awards Committee is excited to introduce the nominees for the 2021… […]
  • Stäubli Robotics appoints new pharma and medical device head
    The mechatronics and robotics company Stäubli (Pfäffikon, Switzerland) has named Olivier Cremoux to be the deputy head of pharma and medical device for Stäubli Robotics North America. Cremoux has worked in various Stäubli divisions since 2015 and has served as an international business development manager. In 2018, he began a stint as a North American… […]
  • Novanta acquires ATI Industrial Automation and its surgical robotics tech
    Novanta today announced that it has agreed to acquire ATI Industrial Automation for $172 million in cash. Bedford, Mass.–based Novanta plans to acquire the OEM surgical robotics supplier for $172 million upfront in cash and additional contingent cash payments associated with company financial performance in 2021. The company will also grant performance stock units. ATI… […]